Refeyn announces appointment of a new CEO

Refeyn, a leading Life Science instrumentation company pioneering mass photometry, announced today that Gerry Mackay has been appointed the new CEO of the company effective January 1st, 2024.  

Back to BPS: Celebrating four years of mass photometry

Four years ago, at the Biophysical Society’s Annual Meeting 2018 in San Francisco, an early mass photometer made its first public appearance, when a University of Oxford team led by Philipp Kukura and Daniel Cole brought a prototype to demonstrate live in the BPS exhibition hall.